Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 27410966)

Published in PLoS One on July 13, 2016

Authors

Katharine Kripke1, Marjorie Opuni2, Melissa Schnure3, Sema Sgaier4,5, Delivette Castor6, Jason Reed6, Emmanuel Njeuhmeli7, John Stover8

Author Affiliations

1: Health Policy Project, Avenir Health, Washington, DC, United States of America.
2: United Nations Joint Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
3: Health Policy Project, Futures Group, Washington, DC, United States of America.
4: Bill & Melinda Gates Foundation, Seattle, WA, United States of America.
5: Department of Global Health, University of Washington, Seattle, WA, United States of America.
6: Office of the U.S. Global AIDS Coordinator and Health Diplomacy, Washington, DC, United States of America.
7: U.S. Agency for International Development, Washington, District of Columbia, United States of America.
8: Health Policy Project, Avenir Health, Glastonbury, CT, United States of America.

Articles cited by this

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69

Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89

Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56

Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet (2014) 3.88

Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. Sex Transm Infect (2006) 3.58

The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS (2013) 2.66

Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs. PLoS Med (2014) 2.26

Updates to the spectrum model to estimate key HIV indicators for adults and children. AIDS (2014) 2.09

Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet (2014) 1.49

Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network. AIDS (2007) 1.38

The past, present and future of HIV, AIDS and resource allocation. BMC Public Health (2009) 1.24

Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia. PLoS One (2015) 1.20

Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services. J Acquir Immune Defic Syndr (2014) 1.15

Measuring performance in the NHS: what really matters? BMJ (2000) 1.02

Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr (2013) 0.85

Articles by these authors

Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014. PLoS One (2016) 2.50

Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces. PLoS One (2016) 1.69

Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting. PLoS One (2016) 1.68

Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting. PLoS One (2016) 1.64

Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography. PLoS One (2016) 1.62

The Cost of Voluntary Medical Male Circumcision in South Africa. PLoS One (2016) 1.58

Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program. PLoS One (2016) 1.56

Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography. PLoS One (2016) 1.47

Modeling Impact and Cost-Effectiveness of Increased Efforts to Attract Voluntary Medical Male Circumcision Clients Ages 20-29 in Zimbabwe. PLoS One (2016) 1.44

Estimating Client Out-of-Pocket Costs for Accessing Voluntary Medical Male Circumcision in South Africa. PLoS One (2016) 1.36

The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania. PLoS One (2016) 0.99